Wolfgang Marguerre (birthed 1941) is a German billionaire entrepreneur, the chairman and also proprietor of the Octapharma Team.
Job
He started Octapharma in 1983 with Robert Taub. Octapharma is had by Marguerre and also his 3 youngsters, 2 of , Frederic Marguerre and also Tobias Marguerre, the monitoring board.
Since November 2016, Forbes approximated his total assets at US$ 5.8 billion.
History
Birthed in Germany in 1941, Marguerre was elevated and also enlightened in Heidelberg, where he Political and also Economic Scientific research at Heidelberg College. He got his MBA at INSEAD [2] in 1972. After which, he was supervisor at Pharmaplast (department of A.P. Möller) for 3 years in Copenhagen, prior to relocating to Baxter-Travenol Europe in Brussels as their supervisor and also manager of Hyland-Division. In 1979, he ended up being elderly exec vice-president of the Revlon Health care Team in Paris, a function which he up until 1983, when he established Octapharma.
Honors
In April 2009, Marguerre was awarded the Légion d’honneur, the greatest design presented by France. In November 2011 he was granted the Gold Design of Honour for Provider to the Republic of Austria (Grosses Goldenes Ehrenzeichen).
Philanthropy
Marguerre sponsors 70 kids with bleeding conditions in India, Nepal, Romania as well as the Philippines with Save One Life, a global non-profit company that sustains kids and also grownups with blood problems.
Passions
Marguerre has actually played the violin because the age of 6. An advocate of the arts, he assisted to conserve the Heidelberg Theater which had actually been endangered with closure. When the theater was resumed in 2012 the recently constructed phase was called the “Marguerre-Saal” (Marguerre Hall) in his honour. Marguerre talks 5 languages.
Marguerre is the co-founder and chairman of Octapharma, a closely held blood plasma separation company. The Lachen, Switzerland-based business reported revenue of 1.7 billion euros ($1.9 billion) in 2017. It has almost 100 plasma donation centers and supports the treatment of patients in 113 countries.
Source:
- Forbes
- bloomberg